Inovio Pharmaceuticals DNA Medicines 2021 Investor Presentation

Inovio Pharmaceuticals presents its DNA medicine platform technology for treating and preventing cancers and infectious diseases. The company has 15 clinical programs in development utilizing precisely designed plasmids delivered through proprietary devices, with well-tolerated immune responses demonstrated across 3,000+ patients and an extensive patent portfolio.